10:31 , Jun 12, 2019 |  BC Extra  |  Company News

Ginkgo invests $80M in Synlogic as partners collaborate on synthetic microbe development

Encouraged by a previous pilot collaboration, Ginkgo will invest $80 million in Synlogic and use its automated cell programming platform to accelerate the development of the latter's pipeline of synthetic microbes. For their initial partnership...
01:15 , Dec 22, 2018 |  BioCentury  |  Product Development

A year of digital progress at Novartis

Novartis AG Chief Digital Officer Bertrand Bodson is capping off his inaugural year with the pharma’s first approval of a digital therapeutic and 10 deals under his belt to integrate new technologies throughout the company....
21:15 , Jul 9, 2018 |  BC Extra  |  Preclinical News

Portable device can produce GMP-quality proteins

A University of Maryland team developed a portable, customizable device that could enable the production of good manufacturing practice (GMP)-quality protein therapeutics at the point of care, which could be used in disaster-stricken or remote...
00:43 , Jun 29, 2018 |  BC Innovations  |  Product R&D

Highly personal

Pact Pharma Inc. has raised $120 million in venture financing to tackle one of the most complex forms of personalized medicine proposed to date: neoantigen-targeted T cells. Backed by Alphabet Inc.’s GV, the company is...
23:35 , Nov 30, 2017 |  BC Week In Review  |  Company News

Thermo Fisher, CBMG to create cell therapy center in China

Thermo Fisher Scientific Inc. (NYSE:TMO) and Cellular Biomedicine Group Inc. (NASDAQ:CBMG) partnered to build the Cell Therapy Technology Innovation and Application Center at CBMG's Shanghai Zhangjiang GMP facility. The partners will perform R&D for an...
08:00 , Dec 24, 2012 |  BC Week In Review  |  Company News

BrainStorm, Octane Medical Group deal

The companies partnered to co-develop a proprietary bioreactor to produce BrainStorm's NurOwn NTF stem cells using Octane Biotech Inc.'s Automated Cell & Tissue Engineering System (ACTES) technology. The project is funded by a three-year grant...
07:00 , Mar 23, 2009 |  BC Week In Review  |  Company News

innovatis AG, Roche deal

Roche will acquire cell analytics supply company innovatis for €15 million ($19.4 million) in cash. innovatis markets products for automated cell analysis, including systems for cell viability, size and biochemical measurements. The deal is expected...
08:00 , Dec 11, 2006 |  BC Week In Review  |  Company News

Immunicon sales and marketing update

IMMC launched its EasyCount fluorescent microscopy-based imaging system for automated cell counting. Immunicon Corp. (IMMC), Huntingdon Valley, Penn.   Business: Supply/Service  ...
07:00 , Aug 15, 2005 |  BC Week In Review  |  Company News

Xantos, Qiagen sales and marketing update

The companies will co-market QIA's TOM-amidite chemistry-based genome-wide RNAi products and Xantos' XantosScreen automated cell-based screening platform. Xantos Biomedicine AG , Martinsreid, Germany   Qiagen N.V. (FSE:QIA; QGEN), Venlo, the Netherlands   Business: Supply/service  ...
08:00 , Nov 17, 2003 |  BC Week In Review  |  Company News

Axaron, Leica Microsystems GmbH sales and marketing update

The companies extended their 2002 co-marketing deal to include Leica's AS LMD Laser Microdissection System and Axaron's Axaminer technology, which includes modules for cell labeling, automated cell isolation, RNA isolation and amplification and transcription profiling....